Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
Tanvex BioPharma USA, Inc

FDA Inspection

•Tanvex BioPharma USA, Inc•January 24, 2023

FDA Inspection 1198180 - Tanvex BioPharma USA, Inc - January 24, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Tanvex BioPharma USA, Inc, with an inspection on January 24, 2023, issued by the Los Angeles District Office.

Company: Tanvex BioPharma USA, Inc
Inspection Date: January 24, 2023
Office: Los Angeles District Office

Open in Dashboard

ID · fa8011ad-a7f3-41ae-b1f0-e2e41019a098

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1198180 - Tanvex BioPharma USA, Inc - January 24, 2023 | KeyPedia